Lfb
Blood & Organ Banks · France · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Lfb Sa 3 Avenue Des Tropiques, Courtaboe...Phone Number
+33 169827010Website
www.groupe-lfb.comRevenue
$742.8 MillionIndustry
ZI Rank: 9
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
7
5
8
15
9
About Lfb
LFB is a biopharmaceutical laboratory that specializes in developing, manufacturing, and marketing plasma-derived medicines and recombinant proteins for healthcare professionals. With a commitment to public health and a focus on rare diseases, LFB serves as a vital link between donors and patients, ensuring responsible and sustainable practices. The company operates internationally, with a strong presence in Europe, the Americas, and other regions, and is dedicated to innovation and corporate social responsibility. LFB aims to improve the lives of patients while supporting healthcare professionals through its advanced biomedical solutions.Explore more
Lfb Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lfb your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Lfb recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Lfb
Check out if Lfb is spiking on competitors!
Product Launch: Get notified when Lfb launches new products
Click to see if Lfb had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Lfb has new funding data
Check if Lfb has recently received funding, and reach out quickly before it becomes old news!
Lfb, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Lfb
Find 2 more new buyers
Company Profile Activity
Activity Insights
Lfb is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Lfb is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Lfb.
Lfb Tech Stack
A closer look at the technologies used by Lfb
See more technologies
Most Recent Scoops
Hiring Plans
Lfb has more open roles in Finance than it has had at any time in the past 6 months.
Hiring Plans
Project
, according to a high-level source in application management, is in the midst of initiatives related to enterprise application integration (EAI).
Integration, Enterprise Software, Software, Enterprise Resource Planning
Project
, according to a high-level source in application management, is in the midst of initiatives related to supply chain management (SCM). Lfb will be increasing funding and is expected to increase permanent employee workforce to support these efforts.
Spending/Investment, Financial Planning, Funding, Logistics / Supply Chain, Finance
Project
, according to a high-level source in application management, is planning to leverage code generation (SaaS) over the next six to twelve months.
Project
Help Desk, Technical Support
Lfb News & Media
LFB Announces the Approval of CEVENFACTA® (eptacog beta) in the European Union
LES ULIS, France--(BUSINESS WIRE)--LFB today announced that the European Medicines Agency (EMA) has granted on July 15th a Marketing Authorisation for CEVENFACTA® (eptacog beta), as the first new bypassing agent in over 20 years. CEVENFACTA® is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups: in patients with congenitalLFB and Kedrion sign an industrial cooperation agreement to supply immunoglobulins to meet patient demand in France
LES ULIS, France and LUCCA, Italy, Jan. 31, 2022 /PRNewswire/ -- Two leading European pharmaceutical companies, LFB and Kedrion, are joining forces in an industrial cooperation agreement to increase the availability of immunoglobulin, a plasma-derived medicine, for patients in France. In...Plasma Collection Market COVID 19 Impact Analysis SWOT Analysis, Key Indicators, Forecast 2028 the Top Companies Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO
London, UK -- (SBWIRE) -- 01/17/2022 -- Plasma Collection Market COVID-19 Impact Analysis, Competitive Landscape, Capital Share Analysis and Forecast Revenue 2022-2028 Read the full press release at http://www.sbwire.com/press-releases/plasma-collection-market-covid-19-impact-analysis-swot-analysis-key-indicators-forecast-2028-the-top-companies-takeda-csl-grifols-octapharma-kedrion-lfb-group-biotest-bpl-raas-cbpo-1351915.htmLFB Plasma Acquires ImmunoTek Bio Center in Greenacres and Establishes Flagship Office in Florida
LFB, a global biopharmaceutical group that develops and markets therapeutics for patients with serious diseases in 30 countries, makes their debut in Florida as "LFB Plasma."
Read more news
Top Blood & Organ Banks Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lfb
Sign Up For FreeTo access detailed company insights
LFB is a biopharmaceutical laboratory that specializes in developing, manufacturing, and marketing plasma-derived medicines and recombinant proteins for healthcare professionals. With a commitment to public health and a focus on rare diseases, LFB serves as a vital link between donors and patients, ensuring responsible and sustainable practices. Th... Read More
